The heterogeneity of changes in incidence and survival among lymphoid malignancies in a thirty-year French population-based registry.

Date publication

août 2014

Auteurs

Membres identifiés du Cancéropôle Est :
Dr CASASNOVAS Olivier , Pr MARTIN Laurent , Pr MAYNADIE Marc

Tous les auteurs :
Dandoit M, Mounier M, Guy J, Petrella T, Girard S, Casasnovas RO, Martin L, Bonnetain F, Maynadie M

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/25166007

Résumé

Abstract Our specialized population-based registry has allowed us to explore changes in incidence and survival by sub-type over the last 30 years. Between 1980 and 2009, 4,790 cases of lymphoid malignancies were registered using the International Classification of Diseases for Oncology. The incidence rate of lymphoid malignancies was 20.5 per 100,000 inhabitants per year, and ranged from 0.1 to 4 according to the subtype. 10-year net survival was 65%, and ranged from 41% to 93% according to the subtype. We observed an increase in 5-year net survival between the period 1980-1989 and 2000-2009 (58% vs. 70%). This was observed in most but not all subtypes. Our long-standing population-based registry allowed us to measure differences in trends according to the subtype of lymphoid malignancies. Incidence rates steadily increased in quite frequent entities and poor survival probability for most entities indicate that they must be the next objective in therapeutic research programs.

Référence

Leuk Lymphoma. 2014 Aug 28:1-13.